Navigation Links
NASA Extends Bioastronautics Contract With Wyle for Total Value of $976 Million
Date:7/27/2009

EL SEGUNDO, Calif., July 27 /PRNewswire/ -- NASA has exercised a $201 million second option on a contract with Wyle to provide continuing support to the Space Life Sciences Directorate at NASA's Johnson Space Center. The option extends the contract to April 30, 2013. The work will be done by Wyle's Integrated Science and Engineering Group, headquartered in Houston.

Under the bioastronautics contract, Wyle's work supports the International Space Station, space shuttle, Constellation and Human Research Programs. Wyle maintains readiness of Space Life Sciences facilities and laboratories.

Wyle provides services for program integration; habitability and environmental factors; human adaptation and countermeasures; space medicine; flight hardware development and human research activities.

Option 2 is a continuation of previous work with the exception that the space shuttle will be retired and no longer supported.

The majority of the work is performed at Johnson Space Center. Work also is performed at launch and landing sites in the United States and Russia, as well as at the University of Texas Medical Branch at Galveston and the Gagarin Cosmonaut Training Center in Moscow.

The contract's base period was from May 1, 2003 to April 30, 2008. Exercising Option 1 in July 2007 extended the contract to April 30, 2011. The base period and Option 1 have a combined value of $775 million. Exercising Option 2 brings the total potential value of the contract to $976 million.

Wyle, a privately held company, is a leading provider of high tech aerospace engineering and information technology services to the federal government on long-term outsourcing contracts. The company also provides life sciences services for NASA's astronaut corps as well as mission critical support services and space simulation; test and evaluation of aircraft, weapon systems, networks, and other government assets; and other engineering services to the aerospace, defense, nuclear power, communications and transportation industries.

    Contact:
    Dan Reeder
    (310) 563-6834
    Ref.:  NR/09-25


'/>"/>
SOURCE Wyle
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. GeneThera Extends its Reach Overseas
2. Insmed Announces That NASDAQ Further Extends Temporary Suspension of Minimum Bid Closing Price Rule
3. Endo Pharmaceuticals Extends Subsequent Offering Period for Indevus Shares Until 5:00 pm EDT on Wednesday, March 18, 2009
4. BVF Acquisition LLC Extends Avigen Tender Offer to April 3, 2009
5. BVF Acquisition LLC Extends Avigen Tender Offer to March 6, 2009
6. BioMed Realty Trust Extends Leases With Vertex Pharmaceuticals Through 2015
7. GlaxoSmithKline Reduces Minimum Tender Condition and Extends Tender Offer To Acquire Genelabs Technologies, Inc.
8. GlaxoSmithKline Extends Tender Offer for Genelabs Technologies, Inc.
9. NASDAQs Temporary Suspension of Minimum Bid Closing Price Rules Extends Insmeds Compliance Date to March 20, 2009
10. Ziehm Imaging Extends its Training Offer
11. Gores Legacy of Innovation Extends From Products to Processes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... November 30, 2016 The global ... players hold a dominant share in the overall market. ... International, Inc., and Merck KGaA, held a lion,s share ... Market Research observes that these companies are expected to ... products that are do not require rabbit pyrogen testing ...
(Date:11/30/2016)... 2016  Tempus, a technology company focused on ... Abramson Cancer Center have partnered to better determine ... immunotherapy treatment based on next generation genomic and ... a research collaboration, Tempus will provide sequencing and ... data to Penn. Utilizing next-generation sequencing, machine learning ...
(Date:11/30/2016)... ... November 30, 2016 , ... SSCI, the established leader ... the implications of the latest FDA guidance on pharmaceutical cocrystals as drug substance ... Cambridge, MA. , The event follows the successful November 15th event that ...
(Date:11/30/2016)... ... 30, 2016 , ... ProMIS Neurosciences (“ProMIS” or the “Company”), ... today announced that all five of its validated monoclonal antibody (mAb) therapeutic candidates ... prion-like forms of Amyloid beta (Aß) in vitro. , “We previously demonstrated that ...
Breaking Biology Technology:
(Date:6/15/2016)... 2016 Transparency Market Research ... Market by Application Market - Global Industry Analysis Size Share ... the report, the  global gesture recognition market  was ... is estimated to grow at a CAGR of ... Increasing application of gesture recognition technology ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. and ... business relationship that includes integrating Syngrafii,s patented LongPen™ ... project. This collaboration will result in greater convenience ... credit union, while maintaining existing document workflow and ... ...
(Date:6/2/2016)... June 2, 2016   The Weather Company , an ... Ads, an industry-first capability in which consumers will be able ... to ask questions via voice or text and receive relevant ... Marketers have long sought an advertising solution ... can be personal, relevant and valuable; and can scale across ...
Breaking Biology News(10 mins):